What is the appropriate management of a zolpidem overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Zolpidem Overdose

Zolpidem overdose is generally benign when taken alone and should be managed primarily with supportive care, including airway management, gastric lavage when appropriate, and monitoring of vital signs, while flumazenil can be considered as an antidote but carries specific risks. 1

Immediate Management

Supportive Care (Primary Approach)

  • Establish and maintain airway patency with bag-mask ventilation or endotracheal intubation if protective airway reflexes are lost 2
  • Administer intravenous fluids as needed for hemodynamic support 1
  • Monitor respiration, pulse, blood pressure, and other vital signs continuously 1
  • Consider gastric lavage when appropriate based on timing and clinical presentation 1

Clinical Presentation by Dose

  • Mild symptoms (somnolence) occur with doses up to 600 mg (60 times the therapeutic dose) in single-drug poisonings 3
  • Coma is rare in isolated zolpidem overdose, occurring primarily in malnourished patients or when combined with other CNS depressants 3
  • Combined intoxications with alcohol or other CNS-active drugs can induce coma at doses as low as 100-150 mg 3

Antidote Consideration: Flumazenil

When to Use

  • Flumazenil (0.2 mg titrated up to 1 mg in adults; 0.01 mg/kg in pediatrics) rapidly reverses zolpidem-induced sedation and respiratory depression within 3 minutes 2, 4
  • Effective in both mono-intoxications and combined poisonings involving zolpidem 3
  • May prevent the need for intubation and mechanical ventilation 2

Critical Contraindications and Risks

  • Do NOT use flumazenil in patients with benzodiazepine tolerance, as it may precipitate refractory withdrawal and seizures 2
  • Contraindicated in patients with preexisting seizure disorders 2
  • May precipitate dysrhythmias (supraventricular tachycardia, ventricular dysrhythmias, asystole) particularly with co-ingestion of dysrhythmogenic drugs like tricyclic antidepressants 2
  • Flumazenil administration may contribute to neurological symptoms including convulsions 1
  • May not fully reverse respiratory depression in mixed overdoses 2

Specific Management Considerations

Avoid Sedating Drugs

  • Withhold all sedating medications following zolpidem overdosage, even if excitation occurs 1

Monitor for CNS Depression and Hypotension

  • Treat hypotension and CNS depression with appropriate medical interventions 1
  • Most patients recover rapidly, with 91% showing symptom remission quickly 5

Observation Period

  • Monitor patients for approximately 24 hours, especially in combined intoxications where coma can develop at relatively low zolpidem doses 3

Role of Dialysis

  • Hemodialysis is NOT effective for zolpidem removal and should not be pursued 1

Poison Control Consultation

  • Contact regional poison centers (1-800-222-1222 in the United States) for expert guidance on specific cases 2
  • Board-certified toxicologists can provide specialized treatment recommendations 2

Prognosis

  • Zolpidem single-drug poisonings are generally benign and require no specific therapeutic measures beyond supportive care 3, 5, 6
  • Severe complications and fatalities in reported cases could not be directly attributed to zolpidem alone 5
  • Combined intoxications carry higher risk and require more intensive monitoring 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Acute overdose of Zolpidem (Stilnox)].

Schweizerische medizinische Wochenschrift, 1996

Research

Acute zolpidem poisoning--analysis of 344 cases.

Journal of toxicology. Clinical toxicology, 1994

Research

General safety profile of zolpidem: safety in elderly, overdose and rebound effects.

European psychiatry : the journal of the Association of European Psychiatrists, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.